Terms ending in 2033
Millennium Pharmaceuticals, Inc.
Every in-force patent on Millennium Pharmaceuticals, Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,663,525 | Pyrazolopyrimidinyl Inhibitors of Ubiquitin-Activating Enzyme In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 9,796,725 | Pyrazolopyrimidinyl Inhibitors of Ubiquitin-Activating Enzyme In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 10,202,389 | Pyrazolopyrimidinyl Inhibitors of Ubiquitin-Activating Enzyme In force · Medium confidence | Takeda Pharmaceutical Company Limited | In force | Medium confidence | |
| US 10,213,436 | Methods of Treating Cancer Using Aurora Kinase Inhibitors In force · High confidence | Millennium Pharmaceuticals, Inc. | In force | High confidence | |
| US 9,290,500 | Pyrazolopyrimidinyl Inhibitors of Ubiquitin-Activating Enzyme In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 9,000,129 | Anti-Gcc Antibody Molecules and Methods for Use of Same In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 9,273,146 | Anti-Gcc Antibody Molecules and Methods for Use of Same In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 9,593,121 | Indole-Substituted Pyrrolopyrimidinyl Inhibitors of UBA6 In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 9,764,033 | Formulation for ANTI-ALPHA4BETA7 Antibody In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 12,286,479 | Treatment with ANTI-ALPHA4BETA7 Antibody In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| 1 more term end in 2033 · Pro | |||||
10 of 11 patents shown. Soonest term end first, then patent number.
Pro members see all 11.
1 of these is in force and held by Millennium Pharmaceuticals, Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.